InvestorsHub Logo
icon url

sts66

01/27/16 5:28 PM

#70256 RE: BioChica #70187

My hunch is the control arm will be switched to EPA, but will not continue.



Those are contradictory statements - if control is switched to EPA, by definition the study continues, but will be unblinded at that point - that actually might be a good idea, assuming interim data is used to approve R-IT indication, to see if the old control group event rate changes after the switch - as long as approval is fast enough for AMRN to afford to continue.